Skip to content

Large-scale study finds no link between MMR vaccine and autism, even among children at higher risk.

In a study that included approximately 95,000 children with older siblings it has been shown that receipt of the measles-mumps-rubella (MMR) vaccine was not associated with an increased risk of autism spectrum disorders (ASD), regardless of whether older siblings had ASD.  The data findings from the Lewin Group indicate no harmful association between receipt of MMR vaccine and ASD even among children already at higher risk for ASD, according to an opensource study published in the journal JAMA.

The team state that although a substantial body of research over the last 15 years has found no link between the MMR vaccine and ASD, a small population of parents and others continue to associate the vaccine with ASD. Surveys of parents who have children with ASD suggest that many believe the MMR vaccine was a contributing cause. This belief, combined with the knowledge that younger siblings of children with ASD are already at higher genetic risk for ASD, might prompt these parents to avoid vaccinating their younger children, according to the current study.

The team examined ASD occurrence by MMR vaccine status in a large sample of U.S. children who have older siblings with and without ASD. The researchers used an administrative claims database associated with a large commercial health plan. Participants included children continuously enrolled in the health plan from birth to at least 5 years of age during 2001-2012 who also had an older sibling continuously enrolled for at least 6 months between 1997 and 2012.

Of the 95,727 children included in the current study, 1,929 (2.01 percent) had an older sibling with ASD. Overall, 994 (1.04 percent) children in the cohort had ASD diagnosed during follow-up. Among those who had an older sibling with ASD, 134 were diagnosed with ASD, compared with the 860 children diagnosed with ASD whose siblings do not have ASD.

The MMR vaccination rate for the children with siblings without ASD in the current study was 84 percent (n = 78,564) at 2 years and 92 percent (n = 86,063) at age 5 years. In contrast, the MMR vaccination rates for children with older siblings with ASD were lower with 73 percent vaccinated at age 2 years and 86 percent vaccinated at age 5 years. Analysis of the data indicated that MMR vaccine receipt was not associated with an increased risk of ASD at any age.

Consistent with studies in other populations the researchers observed no association between MMR vaccination and increased ASD risk among privately insured children.  The team state that they also found no evidence that the receipt of either 1 or 2 doses of MMR vaccination was associated with an increased risk of ASD among children who had older siblings with ASD.

As the prevalence of diagnosed ASD increases, so does the number of children who have siblings diagnosed with ASD, a group of children who are particularly important as they were undervaccinated in the current study as well as in previous reports.

Source:  The JAMA Network Journals

 

No association found between MMR vaccine and autism, even among children at higher risk  - healthinnovations

 

 

Healthinnovations View All

Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.

Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.

Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.

Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.

Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.

An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.

Leave a Reply

Translate »